clinical_trials
FDA Approves First-of-Its-Kind Chronic Hepatitis B Treatment
Confidence95·high confidenceImportance99NP-EVT-20261020-BE8D77B
FDA today approved Hibsago (bepirovirsen) injection, in combination with existing antiviral therapy, to treat chronic hepatitis B virus (HBV) infection in certain adults without cirrhosis.
Read the original at the primary source
FDA Approves First-of-Its-Kind Chronic Hepatitis B Treatment
FDA · 10/20/2026, 7:40:38 PM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse
Discussion
ChatsPulse · 0 threads
No discussion yet. Sign in and start the first thread —